Back

Finerenone in the treatment of cardiac failure in patients with hypertrophic cardiomyopathy

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - The precision care of myocardial disease Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kateryna Amosova

V.N. Karazin National University, Kharkiv (Ukraine)

11 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor G. Streitenberger (Buenos Aires, AR)
Abstract Video
Presentation thumbnail
Doctor L. Gomez (Buenos Aires, AR)
Abstract Video
Presentation thumbnail
Doctor E. Karvouni (Athens, GR)
Abstract Video
Presentation thumbnail
Doctor C. Bergami (Bologna, IT)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - The precision care of myocardial disease

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
High-sensitivity cardiac troponin and the effect of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of FINEARTS-HF
thumbnail
Congress Presentation
Efficacy and safety of finerenone according to frailty in patients with heart failure: a prespecified analysis of the FINEARTS-HF trial
thumbnail
Congress Presentation
Finerenone in patients with heart failure and deterioration in eGFR to <25ml/min/1.73m2 in the FINEARTS-HF Trial

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources